Back to User profile » Professor Kenji Hashimoto

Papers published by Professor Kenji Hashimoto:


Impact of serotonin transporter gene on rTMS augmentation of SSRIs for obsessive compulsive disorder

Zhang K, Fan X, Yuan J, Yin J, Su H, Hashimoto K, Wang G

Neuropsychiatric Disease and Treatment 2019, 15:1771-1779

Published Date: 2 July 2019

Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study

Beyazyüz M, Küfeciler T, Bulut L, Ünsal C, Albayrak Y, Akyol ES, Baykal S, Kuloglu M, Hashimoto K

Neuropsychiatric Disease and Treatment 2016, 12:1261-1268

Published Date: 23 May 2016

Genetic association between G protein-coupled receptor kinase 6/β-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia

Oda Y, Kanahara N, Kimura H, Watanabe H, Hashimoto K, Iyo M

Neuropsychiatric Disease and Treatment 2015, 11:1845-1851

Published Date: 29 July 2015

Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome

Akyol ES, Albayrak Y, Beyazyüz M, Aksoy N, Kuloglu M, Hashimoto K

Neuropsychiatric Disease and Treatment 2015, 11:865-872

Published Date: 30 March 2015

Tipepidine in adolescent patients with depression: a 4 week, open-label, preliminary study

Sasaki T, Hashimoto K, Tachibana M, Kurata T, Kimura H, Komatsu H, Ishikawa M, Hasegawa T, Shiina A, Hashimoto T, Kanahara N, Shiraishi T, Iyo M

Neuropsychiatric Disease and Treatment 2014, 10:719-722

Published Date: 5 May 2014

Tipepidine in children with attention deficit/hyperactivity disorder: a 4-week, open-label, preliminary study

Sasaki T, Hashimoto K, Tachibana M, Kurata T, Okawada K, Ishikawa M, Kimura H, Komatsu H, Ishikawa M, Hasegawa T, Shiina A, Hashimoto T, Kanahara N, Shiraishi T, Iyo M

Neuropsychiatric Disease and Treatment 2014, 10:147-151

Published Date: 24 January 2014

Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine

Ünsal C, Albayrak Y, Albayrak N, Kuloğlu M, Hashimoto K

Neuropsychiatric Disease and Treatment 2013, 9:1545-1552

Published Date: 11 October 2013